O conteúdo desse portal pode ser acessível em Libras usando o VLibras


Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 125 de 933 resultados encontrados
Opções avançadas
Data de publicação: 31/10/2022 - 16:42
The Fiocruz Observa Infância made a survey on infant malnutrition which showed that the rates for babies below one year old have been rising in Brazil. Data show that in 2021 the Unified Health System (SUS, the Brazilian public health system) recorded an average of eight infant hospitalizations per day due to malnutrition, a consequence of nutritional deficiencies in this age group. There were a total of 2,979 hospitalizations for this age...
Data de publicação: 31/10/2022 - 15:28
An unpublished study led by Fiocruz Amazônia evaluated the excess maternal deaths in Brazil during the first 15 months of the COVID-19 pandemic. Epidemiologist Jesem Orellana, of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazônia), together with researchers from Brazilian, Colombian and North-American universities, showed the very worrying increase in maternal deaths in Brazil, especially during the trimester from...
Data de publicação: 31/10/2022 - 13:51
Last Monday (24 October), Nísia Trindade Lima, president of Fiocruz, was granted the official certificate of the 2022 Brazilian Women Making a Difference Award. The award is granted by the US embassy and consulates in Brazil, as acknowledgement to relevant women all over the country. The certificate was handed to Lima by Mark Carr, cultural attaché of the United States Consulate in Rio de Janeiro, who visited the Foundation in the...
Data de publicação: 27/10/2022 - 14:40
A study by researchers from Fiocruz and from Estácio University shows a 19% excess of deaths in 2020, the first year of the COVID-19 in the country. The group of infectious and parasitic diseases was the one that stood out the most from among the defined causes of death. The goal of the analysis was to estimate excess mortality in Brazil and in the states during that period, assuming it was different for each group of causes of death...
Data de publicação: 21/10/2022 - 12:29
Fiocruz researchers participated, on Tuesday (Oct/18), in the 8th Global Forum of the Milan Urban Food Policy Pact (MUFPP), an event that, for the first time, took place in South America. The 2022 edition of the Forum, which was supported by Rio de Janeiro’s Local Government, had as its theme Food to Feed the Climate Justice: urban food solutions for a fairer world. For three days, more than 500 delegates from 162 cities around the world...
Data de publicação: 19/10/2022 - 11:47
Flock (Revoada), the documentary that records the health expeditions of the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) in the Triple Border region of the state of Amazonas, during the critical period of the COVID-19 pandemic in 2021, is one of the nominees for the Award of Latin American Independent Film Festival (Mira), which will take place in Germany from 20 to 23 October. The film will have its world premiere at...
Data de publicação: 18/10/2022 - 14:44
At Fiocruz and around the world, the relevance of Open Access (OA) is well-known. Open Access means the free availability of scientific and technical digital content to anyone. Since 2014, the Foundation has established a Policy on Open Access to Knowledge, that refers to strengthening the mechanisms of protection and visibility of its scientific production, increasing its impact, and contributing to science development. Due to its increasing...
Data de publicação: 13/10/2022 - 10:53
During his participation in a seminar organized by Fiocruz last Wednesday (5 October), the newly elected director of the Pan-American Health Organization (PAHO), Jarbas Barbosa, mentioned challenges in the region, such as the effects of the pandemic, the persistence of communicable diseases, the need to strengthen primary healthcare and the production of inputs, such as vaccines, in the region. The Brazilian public health physician also spoke...
Data de publicação: 11/10/2022 - 15:31
To achieve more effective and equitable results in terms of drug policy, it must be seen from a perspective of gender and of region. Once we look at these women, we must still understand who they are, in their diversity. This was one of the points discussed at the Regional Meeting of Combined HIV Prevention and healthcare lines for women who use drugs, which took place last Monday and Tuesday (September 26 and 27) at the Fernandes Figueira...
Data de publicação: 11/10/2022 - 15:06
Published in the Journal of Molecular Cell Biology, a Fiocruz study proves that Apixaban, an oral anticoagulant, effectively inhibits the replication of the Sars-CoV-2 virus, which causes COVID-19. This type of drug had already been recommended to prevent high levels of D-dimer, the final product of the coagulation cascade and directly related to severe COVID-19. Fiocruz researchers, however, discovered that the drug also has an antiviral...
Data de publicação: 11/10/2022 - 10:10
The fungus that causes histoplasmosis, a disease that can affect the lungs and lead to death, was detected in Antarctica for the first time, as revealed by the study Molecular Detection of Histoplasma capsulatum in Antarctica. Written by Fioantar researchers, the paper is part of the October issue of the Emerging Infectious Diseases Journal, published by the Centers for Disease Control and Prevention (CDC) of the United States, and is one of the...
Data de publicação: 10/10/2022 - 16:55
SpiN-TEC, a COVID-19 vaccine developed by Fiocruz Minas and by the Federal University of Minas Gerais (UFMG), can begin to be tested in humans. Last Monday (October 3), the Brazilian Health Surveillance Agency (Anvisa) authorized the beginning of the so-called clinical trials. From now on, researchers can move on to the step that evaluates the safety and the immune response generated by the vaccine. In this new phase, the immunizer will be...
Data de publicação: 06/10/2022 - 11:07
In people who received two doses of the inactivated Coronavac vaccine, an mRNA boost offers considerably better protection against mild and severe COVID-19 than a boost with the same vaccine, according to a large observational study performed in Brazil and co-led by Fiocruz and the Barcelona Institute for Global Health (ISGlobal), an institution supported by “La Caixa” Foundation. These findings, published in Nature Communications,...
Data de publicação: 03/10/2022 - 16:11
By means of its Center for Technological Development in Health (CDTS), Fiocruz is now part of  Repurposing of Medicines 4ALL – REMEDI4ALL, a project financed by the European Commission with the goal of supporting medicines repurposing. Initially conceived to work for five years and with a budget of 25 million euros, the platform is made up of 26 institutions from all over the world, including hospitals, research institutions,...
Data de publicação: 28/09/2022 - 16:09
In a recent qualification course on the diagnosis of tegumentary leishmaniasis and patient care, health workers from Belize, a country in the East coast of Central America, were trained in Porto Velho. Attendants were able to follow, in practical terms, all phases of the care provided to previously scheduled patients, from reception and medical consultation at the dermatology clinic of the Rondônia Center for Tropical Medicine (Cemetron)...
Data de publicação: 26/09/2022 - 11:04
Social and environmental determinants of health are the main investigation subject of a vast research program led by the Centre for Data and Knowledge Integration for Health (Cidacs/Fiocruz Bahia) together with researchers from Brazil, the United Kingdom, and Ecuador. Brazilian and European investigators had already been dedicated to studies that evaluate the impacts of public policies on social inequalities in health in Brazil since 2017,...
Data de publicação: 23/09/2022 - 15:58
Between January and August 2019, sixteen indigenous children died in Alto do Rio Purus, in the state of Acre. The youngest was only a one-month-old baby. All died of diarrhea. These cases are worthy of notice and science show that it is not a temporary crisis. We are talking about a chronic condition caused by the living and health conditions of indigenous children in Brazil. According to an article published in the October issue of The Lancet...
Data de publicação: 23/09/2022 - 11:18
Through its Institute of Technology in Immunobiologicals (Bio-Manguinhos), Fiocruz was granted by the Brazilian Health Regulatory Agency, last Tuesday (20 September) the definitive registration for the OPXV/MPXV/VZV/RP Multiplex Molecular Kit for the diagnosis of monkeypox and other diseases with similar symptoms, in a differential manner. The Institute, therefore, becomes the holder of the first registration of a diagnostic product for the...
Data de publicação: 22/09/2022 - 13:19
Over the last century, poliomyelitis affected hundreds of thousands of people, causing irreversible paralysis and claiming lives. Global vaccination efforts against this infectious and contagious disease, however, managed to drastically reduce its dissemination and impact. These efforts are currently being put to the test by recent challenges such as the Covid-19 pandemic, natural disasters, and armed conflicts, in addition to vaccine hesitation...
Data de publicação: 20/09/2022 - 16:26
Researchers at the Carlos Chagas Institute (Fiocruz Paraná) have used techniques such as artificial intelligence (AI) to assess the influence of exposome on skin health. It is the combination of environmental, behavioral and hormonal factors (such as UV radiation, smoking and pollution) that cumulatively can affect the skin's biological functions and accelerate its aging. The study won the Vichy Exposome Grant 2022, one of the most...
Data de publicação: 01/11/2022 - 14:40
Boletim Internacional
Data de publicação: 14/09/2022 - 11:52
The Management Report, published on June 2, offers a thorough picture of the efforts undertaken by Fiocuz to offer quick responses to the Brazilian population in the fight against COVID-19. From the generation of knowledge and the diffusion of technical information for the population and managers to the unprecedented technology transfer that made it possible to manufacture vaccines that are 100% Brazilian, therefore ensuring the immunization of...
Data de publicação: 06/09/2022 - 14:37
The Oswaldo Cruz Foundation (Fiocruz) publishes its Letter to Candidates for the Presidency and Society. With the title Sustainable Development with Equity, Health and Democracy, the document seeks to contribute to the electoral debate, based on ten guidelines, which summarize a set of proposals for fields directly related to Brazilians' health and the country's development. The letter was sent to the campaign coordinators of all...
Data de publicação: 31/08/2022 - 17:06
Image obtained by researchers at the Oswaldo Cruz Institute (IOC/Fiocruz) shows the moment in which a cell undergoes a degeneration process after infection by the monkeypox virus. Cell alteration caused by viral infection (photo: Milene Dias Miranda, IOC/Fiocruz) To capture the cytopathic effect in monolayer, as it is called scientifically, inoculation of the clinical sample from an infected patient into Vero lineage cells, a model often...
Data de publicação: 31/08/2022 - 15:35
In 1848, Phineas Gage, a 25-year-old American railroad worker had his skull pierced by an iron bar, which caused damage to his frontal lobe. After that, Gage showed changes in his personality, attributed at the time to possible injuries to his left frontal region. On August 15, 2012, 24-year-old Brazilian E.L. suffered a similar accident at a construction site: a rebar fell from the 5th floor piercing the right side of his skull and his frontal...


Back to the topBack